Overview on population screening for carriers with germline BRCA mutation in China.

Lei, Huijun; Zhang, Min; Zhang, Luyao; Hemminki, Kari; Wang, Xiao-Jia; Chen, Tianhui

Lei, Huijun; Zhang, Min; Zhang, Luyao; Hemminki, Kari; Wang, Xiao-Jia; Chen, Tianhui.

Afiliação

Lei H; Department of Cancer Prevention/Zhejiang Cancer Institute, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China.
Zhang M; Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
Zhang L; School of Public Health, Hangzhou Medical College, Hangzhou, Zhejiang, China.
Hemminki K; Department of Cancer Epidemiology and Prevention, Henan Engineering Research Center of Cancer Prevention and Control, Henan International Joint Laboratory of Cancer Prevention, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
Wang XJ; Biomedical Center, Faculty of Medicine, Charles University in Pilsen, Pilsen, Czechia.
Chen T; Division of Cancer Epidemiology, German Cancer Research Center Deutsches Krebsforschungszentrum (DKFZ), Im Neuenheimer Feld, Heidelberg, Germany.

Front Oncol ; 12: 1002360, 2022.

Article em En | MEDLINE | ID: mdl-36439508

Palavras-chave

BRCA; China; familial risk; germline mutation; population screening

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Risk_factors_studies / Screening_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google